Plenary Session IV - The Opioid Epidemic and Neuromodulation: Understanding its Role in Treatment Featured

10:30 AM - 12:00 PM Saturday, January 19

The opioid crisis in the United States has brought about the rapid need for understanding the optimal role and the advancement of non-opioid forms of pain control. This session will highlight the current challenges surrounding opioids and the role that neuromodulation and innovative technologies may have in providing successful treatment strategies.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe the current opioid epidemic.
  • Explain the role of neuromodulation in assisting with pain control with the goal of reducing opioid use.
  • Discuss the role of neuromodulation in treating severe opioid addiction.
  • Identify risk factors for opioid misuse and abuse.

AANS and AMA Taskforce Response to Opioids

Jennifer A. Sweet, MD

Opioids and Neuromodulation: A Viable Tool to Reduce Use and Best Practice Strategies

Salim M. Hayek, MD, PhD

Neuromodulation to Treat Severe Opioid Addiction: Reality or Fantasy

Ali R. Rezai, MD

Keynote Speaker—Dreamland: America's Opiate Epidemic and How We Got Here

Sam Quinones


Faculty subject to change.